Why health is becoming the foundation of modern beauty.

The beauty industry is entering a structural shift. Not driven by marketing narratives or short-term trends, but by a deeper reality: health is becoming central to how consumers, scientists and brands understand personal care.

Today, 46% of consumers define beauty as “looking healthy”, and 75% associate beauty routines with wellbeing and confidence. At the same time, dermatological signals are intensifying. Contact allergies affect ~27% of Europeans, and dermatology waiting lists have increased 82% in recent years (Source: European Academy of Dermatology & Venereology, NHS / BAD).

These are not isolated indicators. They reflect a system under pressure.

Through my work at Auê Natural, discussions with EU formulators, green chemistry experts, and academic collaborations, as well as a session I curated at COP30 with Embrapa alongside dermatologists and scientists, one conclusion is clear: health is no longer adjacent to beauty. It is becoming its foundation.

Earlier exposure is reshaping risk and responsibility.

Consumers are entering beauty routines earlier than ever, with behaviour heavily influenced by digital ecosystems. Today, 85% of Gen Z purchase beauty influenced by social media (Source: ICSC / Euromonitor synthesis).

This creates a fundamental shift. Beauty is no longer episodic. It is long-term, cumulative exposure.

In an internal predictive modelling study conducted with a data scientist from Monash University, we observed signals suggesting that prolonged exposure during developmental years could increase lifetime cancer risk by ~22%, depending on exposure timing and compound mix.

This is not a clinical longitudinal data. It is a suggestion that formulation decisions today must consider lifetime exposure pathways, not just short-term efficacy.

The skin is not only a surface. It is a system interface.

Clinical observations increasingly highlight the skin as a route of systemic exposure, not just a cosmetic surface.

Links are being explored between chemical exposure and conditions such as skin allergies, hormonal disruption, reproductive issues and early puberty.

At the same time, access to dermatological care remains limited. In a large European survey, only around 40% of adults reported visiting a dermatologist in the past three years (Source: https://pubmed.ncbi.nlm.nih.gov/37806001/).

From a formulation and brand perspective, this reframes responsibility. Products are not only delivering visible results. They are part of a broader health interface with the human body.

Biodiversity and green science are redefining formulation pathways.

If health is the goal, formulation must evolve. At COP30, in a session I curated with Embrapa and leading experts including a head dermatologist in Brazil and scientific researchers, we explored how biodiversity and biotechnology can converge to create new ingredient systems.

The Amazon rainforest alone holds vast molecular diversity. Ingredients such as buriti, açaí, pracaxi and andiroba offer antioxidant, anti-inflammatory and lipid-rich profiles that can support modern formulations.

Importantly, these are not positioned as nostalgic or “natural alternatives”. They are functional, scientifically relevant inputs, increasingly validated by green chemistry and biotechnology.

Alongside this, the industry is rethinking its material systems. Each year, 120 billion beauty packages are discarded, and 77% of products still contain microplastics or synthetic polymers.

From optional to essential: the future of beauty is health-led